新型无沟槽烟囱支架系统治疗主动脉弓夹层的早期结果
一项前瞻性单中心临床试验纳入13例主动脉弓夹层男性患者,测试新型无沟槽烟囱支架系统。所有患者均于左锁骨下动脉置入烟囱分支支架,术后即刻Ⅰa型内漏发生率为23.1%,延迟性Ⅰa型内漏为7.7%,2年生存率和烟囱支架通畅率均为100%。
要点
- 新型无沟槽烟囱支架系统用于主动脉弓夹层早期技术成功,无沟槽设计可能减少内漏。
- 术后即刻Ⅰa型内漏发生率23.1%,延迟性Ⅰa型内漏7.7%。
- 2年生存率及烟囱支架通畅率均达100%,早期随访结果良好。
核心结论
- 新型无沟槽烟囱支架系统治疗主动脉弓夹层早期成功,内漏发生率可接受,术后生存及分支支架通畅率优异。
主要发现
- 13例患者均为男性,年龄52.6±10.4岁。
- 植入时间14.0±6.9分钟,总手术时间89.5±19.8分钟,造影剂用量79.6±7.2 ml。
- 共植入15枚主动脉支架,所有患者均于左锁骨下动脉(LSA)置入烟囱分支支架。
- 术后即刻Ⅰa型内漏3例(23.1%),延迟性Ⅰa型内漏发生率7.7%。
- 2年生存率100%,烟囱支架2年通畅率100%。
临床怎么用
- 对于主动脉弓夹层,可考虑使用新型无沟槽烟囱支架系统行烟囱TEVAR,早期结果良好。
- 术后需关注Ⅰa型内漏,包括即刻和延迟发生,必要时密切随访。
局限性
- 单中心小样本早期结果,需多中心临床试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Discuss the clinical value, technique characteristics, and early follow-up results of a newly designed gutter-free chimney stent-graft system for aortic arch pathology. METHODS AND RESULTS: About 13 patients with aortic arch dissection were enrolled in a clinical trial testing a novel gutter-free stent-graft between February 2019 and December 2020. All 13 patients were male, age 52.6±10.4 years. The implantation time was 14.0±6.9 minutes; total procedure time was 89.5±19.8 minutes. The volume of contrast was 79.6±7.2 ml. And 15 aortic stent-grafts were implanted, and all 13 patients had chimney branch stent-grafts implanted into the left subclavian artery (LSA). There were 3 (23.1%) cases of immediate type Ιa endoleak after thoracic endovascular aortic repair (TEVAR), and 7.7% type Ιa endoleaks occurred in delayed fashion. Survival at 2 years was 100%, and the 2-year patency of chimney stent-grafts was 100%. CONCLUSIONS: This study reports early success with good freedom from endoleak using a novel stent-graft designed for chimney TEVAR to treat aortic arch dissection. Postoperative survival and patency of the branch stent-grafts were excellent. Additional data from this multicenter clinical trial will be forthcoming.
引用
- Shu C, Li X, Dardik A, et al. Early Results of a Novel Gutter-Free Chimney Stent-Graft System to Treat Aortic Arch Dissection: Single-Center Data from a Prospective Clinical Trial. J Endovasc Ther. 2021. PMID: 34521237. doi:10.1177/15266028211045699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。